In 2012, En. Samidin, a man in his 70s, was diagnosed with a benign bladder cancer with a large leiomyoma, a benign tumor arising from smooth muscle tissue. The tumor originated in the pelvic region and was attached to the outer wall of his bladder. Measuring an extraordinary 23 cm, the tumor posed significant challenges due to its location and size. Surgical removal would have necessitated a total bladder resection, which carried high risks, including the possibility of severe complications and tumor recurrence.
2012年，年逾70的Samidin先生被诊断出患有一种良性膀胱癌，伴有一个巨大的平滑肌瘤（一种起源于平滑肌组织的良性肿瘤）。肿瘤起源于骨盆区域，并附着在膀胱的外壁上。这个肿瘤尺寸巨大，达23厘米，由于其位置和大小，给治疗带来了显著挑战。直接手术切除将需要进行全膀胱切除手术，这存在高风险，包括严重并发症的可能性以及肿瘤复发的风险。As an alternative to direct surgery, En. Samidin initiated a six-month course of ECCT as Bladder Cancer Treatment Options. ECCT works by disrupting the electrical environment that supports tumor growth, weakening the tumor and reducing its adhesion to surrounding tissues. This preparatory treatment enabled his surgeons to perform a clean and complete tumor excision without affecting other organs.
作为直接手术的替代方案，Samidin先生开始了为期六个月的ECCT治疗作为膀胱癌治疗选项。ECCT通过干扰支持肿瘤生长的电气环境起作用，从而削弱肿瘤并减少其对周围组织的粘连。这种准备性治疗使他的外科医生能够在不影响其他器官的情况下，进行干净彻底的肿瘤切除手术。After surgery, En. Samidin resumed ECCT therapy as a preventive measure to reduce the risk of recurrence. Follow-up assessments over the next five years showed no signs of tumor regrowth, confirming the success of this combined approach.
术后，Samidin先生恢复了ECCT治疗，作为预防措施以降低复发风险。在接下来的五年随访中，没有发现肿瘤再生的迹象，这证明了这种综合方法的成功。Now, more than a decade since his initial diagnosis, Mr. Samidin remains in good health and leads an active life. His journey exemplifies how innovative therapies like ECCT can complement traditional surgery, providing safe and effective treatment options for challenging cases.
如今，自最初诊断以来已超过十年，Samidin先生仍然保持健康并过着积极的生活。他的经历证明了像ECCT这样的创新疗法如何能够补充传统手术，为具有挑战性的病例提供安全有效的治疗选择。
ความคิดเห็น